References
- Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412–20.
- Hein KD, Mulliken JB, Kozakewich HP, Upton J, Burrows PE. Venous malformations of skeletal muscle. Plast Reconstr Surg 2002;110:1625–35.
- Kaji N, Kurita M, Ozaki M, Experience of sclerotherapy and embolosclerotherapy using ethanolamine oleate for vascular malformations of the head and neck. Scand J Plast Reconstr Surg Hand Surg 2009;43:126–36.
- Upton J, Coombs CJ, Mulliken JB, Burrows PE, Pap S. Vascular malformations of the upper limb: a review of 270 patients. J Hand Surg 1999;24A:1019–35.
- Gorriz E, Carreira JM, Reyes R, Intramuscular low flow vascular malformations: treatment by means of direct percutaneous embolization. Eur J Radiol 1998;27:161–5.
- Muchemwa FC, Ishihara T, Matsushita S. Intramuscular venous malformation in the upper arm with gross calcifications and compression of the ulnar nerve. Scand J Plast Reconstr Surg Hand Surg 2007;41:93–5.
- Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 1999;104:1–15.
- de Lorimier AA. Sclerotherapy for venous malformations. J Pediatr Surg 1995;30:188–93.
- Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg 2003;37:533–8.
- O'Donovan JC, Donaldson JS, Morello FP, Pensler JM, Vogelzang RL, Bauer B. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR 1997;169:723–9.
- Kaji N, Harii K. Establishment of embolosclerotherapy for vascular malformations of the head and neck; Evaluation of the response rate based on MRI. J Kyorin Med Soc 2006;37:43–54.
- Kimura T, Matsumoto S, Tazaka O, The histologic effects of sclerosant ethanolamine oleate in the rabbit ear vessel model. Jpn J Phlebol 1993;4:159–65.
- Arneja JS, Gosain AK. Vascular malformations. Plast Reconstr Surg 2008;121:195e–206e.
- Miyoshi H, Ohshiba S, Matsumoto A, Takada K, Umegaki E, Hirata I. Haptoglobin prevents renal dysfunction associated with intervariceal infusion of ethanolamine oleate. Am J Gastroenterol 1991;86:1638–41.
- Park JO, Lee SI. Measuring response in solid tumors: comparison of RECIST and WHO response criteria. Jpn J Clin Oncol 2003;33:533–7.
- Frey M, Gruber H, Havel M, Steiner E, Freilinger G. Experimental free-muscle transplantation with microneurovascular anastomoses. Plast Reconstr Surg 1983;71:689–702.
- Kitano S, Iso Y, Koyanagi N, Higashi H, Sugimachi K. Ethanolamine oleate is superior to polidocanol (aethoxysklerol) for endoscopic injection sclerotherapy of esophageal varices: a prospective randomized trial. Hepatogastroenterology 1987;34:19–23.
- Matsumoto K, Nakanishi H, Koizumi Y, Seike T, Kanda I, Kubo Y. Sclerotherapy of hemangioma with late involution. Dermatol Surg 2003;29:668–71.
- Matsumoto K, Nakanishi H, Seike T, Koizumi Y, Mihara K, Kubo Y. Treatment of pyogenic granuloma with a sclerosing agent. Dermatol Surg 2001;27:521–3.
- Orikasa K. Studies on the damage of the cultured endothelial cells and K-562 cells by sclerosants (ethanolamine oleate, Aethoxysklerol and absolute ethanol) used for treatment of esophageal varices. Jpn J Gastroenterol 1998;86:2365–72.
- Mol W, Furukawa H, Sasaki S. Evaluation of the sclerotherapeutic efficacy of ethanol, polidocanol, and OK-432 using an in vitro model. Dermatol Surg 2007;33:1452–9.